| 000 | 01337 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515155227.0 | ||
| 264 | 0 | _c20090323 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1538-7445 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-08-0676 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrédan, Olivier | |
| 245 | 0 | 0 |
_aThe hypoxia-activated ProDrug AQ4N penetrates deeply in tumor tissues and complements the limited distribution of mitoxantrone. _h[electronic resource] |
| 260 |
_bCancer research _cFeb 2009 |
||
| 300 |
_a940-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnthraquinones _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacokinetics |
| 650 | 0 | 4 | _aCell Hypoxia |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aGarbens, Alaina B | |
| 700 | 1 | _aLalani, Alshad S | |
| 700 | 1 | _aTannock, Ian F | |
| 773 | 0 |
_tCancer research _gvol. 69 _gno. 3 _gp. 940-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-08-0676 _zAvailable from publisher's website |
| 999 |
_c18622354 _d18622354 |
||